Although outpatient specialty palliative-care clinics improve outcomes, there is no
consensus on who should be referred or the optimal timing for referral. In response to this …

Background Guidelines suggest limited and cautious use of antipsychotics for treatment of
delirium where nonpharmacological interventions have failed and symptoms remain …

Background Although delirium is typically an acute reversible cognitive impairment, its
presence is associated with devastating impact on both short‐term and long‐term outcomes …

Background: Delirium is a serious neuropsychiatric syndrome frequently experienced by
palliative care inpatients. This syndrome is under-recognized by clinicians. While screening …

Purpose The vast majority of patients with cancer at the end of life receive parenteral
hydration in hospitals and no hydration in hospice, with limited evidence supporting either …

Background: Delirium is a common and distressing neurocognitive condition that frequently
affects patients in palliative care settings and is often underdiagnosed. Aim: Expanding on a …

Importance The use of benzodiazepines to control agitation in delirium in the last days of life
is controversial. Objective To compare the effect of lorazepam vs placebo as an adjuvant to …

Delirium is a neurocognitive syndrome arising from acute global brain dysfunction, and is
prevalent in up to 42% of patients admitted to palliative care inpatient units. The symptoms of …

Delirium is a neurocognitive syndrome that commonly occurs in older populations and
people with cancer, particularly in those with advanced disease and in the last hours or days …

Hypoactive delirium tends to capture less clinical attention than hyperactive delirium. Like all
delirium, it can occur in a variety of patients and settings and will consequently be …